InDevR
About InDevR
InDevR is a life sciences tools company that specializes in advanced analytical technologies for the vaccine and biotherapeutics markets. The company develops and manufactures innovative instruments and consumable assay kits designed to accelerate vaccine and biotherapeutic development and production. Their flagship product line, VaxArray®, is a microarray-based system for multiplexed quantification of critical quality attributes such as protein concentration and potency. This platform offers specific kits for various vaccines, including influenza, measles, rubella, polio, and pneumococcal, as well as for mRNA-based therapeutics. InDevR also offers the CypherOne system for automated hemagglutination assays, supporting quality control across diverse vaccine types, including mRNA, protein-based, and viral vectors.
InDevR’s technologies are crucial for physicians and researchers involved in vaccine development and biopharmaceutical manufacturing. The VaxArray platform, for instance, allows for rapid, multiplexed potency assays, combining multiple tests into one to assess antigen integrity, potency, capping efficiency, and intactness, significantly faster than traditional methods. This is vital for R&D, clinical trials, and release testing. The company’s focus on ease of use, standardization, and automation, including 21 CFR Part 11-compliant software and off-the-shelf/custom kits, aims to reduce user error and ensure consistency across different sites, supporting global quality initiatives. InDevR also provides expert services, offering custom assay development, contract multiplex testing, and specialized vaccine testing services to address development bottlenecks and accelerate analysis and validation of vaccines and biotherapeutics. They are a wholly owned affiliate of SSI Diagnostica A/S.
Focus Areas
Business Intelligence
| Technology | VaxArray® platform (microarray-based system for multiplexed quantification), CypherOne system (digital imaging and automated interpretation of hemagglutination assays) |
What Physicians Need to Know
For physicians, InDevR's technologies, particularly their multiplexed assays, offer significant advantages in diagnostics and patient management. The ability to simultaneously test for multiple antigens or antibodies can lead to faster and more comprehensive diagnostic results, potentially reducing the time to diagnosis and treatment initiation. [2, 4, 6, 7] For example, their FluChip-8G™ IVD product aims to enable physicians to identify seasonal influenza viruses and distinguish them from novel potentially pandemic influenza viruses. [5] The rapid turnaround times for assays, such as the VaxArray Polio Assay Kit which quantifies all three poliovirus serotypes in less than 3 hours, can be critical in situations requiring quick decisions. [6] Furthermore, the ISO 13485 certification for their assay kit production ensures that the diagnostic tools physicians use meet international quality standards, contributing to reliable and accurate patient care. [5, 21, 22, 23, 27] While InDevR primarily focuses on the analytical tools for vaccine and biotherapeutic development, the underlying technologies can translate to improved diagnostic capabilities that directly benefit patient care by providing more efficient and accurate information for clinical decision-making. Physicians in specialties like infectious disease, immunology, and public health could particularly benefit from the rapid, multiplexed testing capabilities for disease surveillance, outbreak response, and monitoring vaccine efficacy. [2, 13]
InDevR's systems are designed with laboratory information system (LIS) integration and 21 CFR Part 11-compatible data handling, facilitating seamless integration into existing laboratory workflows and ensuring data integrity and compliance. [1, 3, 4, 7]
Videos
News, demos, and interviews about InDevR.
Videos load interactively. If none appear, search YouTube for InDevR →
Frequently Asked Questions
Related Companies
PathologyAILab offers advanced digital cytology services, leveraging a multi-agent AI system for cervical cancer diagnosis. This innovative solution provides comprehensive image analysis to deliver precise and reliable diagnostic insights to healthcare professionals. The service aims to provide rapid results, typically within 2-4 hours, for urgent cases, enabling timely clinical decisions. The process involves submitting digital […]
Ottobock Healthcare Products, an international company based in Duderstadt, Germany, is a global leader in orthopedic technology, specializing in prosthetics, orthotics, wheelchairs, and exoskeletons. Founded in 1919, the company’s mission is to restore and improve independence for individuals with mobility challenges through technological innovation, advanced biomechanics, and advancements in neuromobility. They offer a comprehensive portfolio […]
Bonraybio Co., Ltd. (stock code: 6955) is dedicated to advancing medical innovation and focusing on health, aiming to enhance global medical quality in the reproductive field. The company specializes in providing comprehensive solutions for male infertility, recognizing the increasing challenges posed by aging populations and rising infertility rates worldwide. Their mission is to address the […]
Vitestro is a healthcare AI company that has developed Aletta®, the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). This device automates the diagnostic blood collection process, aiming to set a new standard for blood collection. Vitestro’s technology is designed to address global challenges in manual phlebotomy, such as staffing constraints, heavy workloads, and variability in […]
